Transcription profiling of human response to etanercept treatment in patients with Psoriasis
Ontology highlight
ABSTRACT: The success of TNF inhibitors for treatment of psoriasis and other inflammatory diseases was previously attributed to blockade of innate immunity. In a clinical trial using etanercept TNF blocking agent to treat psoriasis vulgaris, we used affymetrix gene arrays to analyze broad gene profiles in lesional skin at multiple timepoints during drug treatment (baseline, and weeks 1, 2, 4 and 12) compared to non-lesional skin. This analysis created a temporal model of TNF-dependent gene regulation that informs molecular mechanisms of TNF-mediated inflammation. We identified four gene clusters that were differentially down-modulated during etanercept treatment: the cluster down-regulated most rapidly contained mostly dendritic cell activation genes. Culturing human keratinocytes with TNF, IFNg
ORGANISM(S): Homo sapiens
SUBMITTER: Mayte Suarez-Farinas
PROVIDER: E-GEOD-11903 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA